Another chemotherapy reaction? Hyperpigmentation due to alkylating agents revisited

Anti-itching and barrier restoring effects of alipid-replenishing balm on atopic dermatitis models

Antibiotic therapy for Staphylococcus aureus colonisedvascular catheter tips and the occurrence ofbacteraemia – implications for hospital policy

Approach to hypopigmentation or depigmentationin children

Apremilast, an oral phosphodiesterase 4 inhibitor, inpatients with moderate to severe psoriasis: 52-weekresults of the ESTEEM 2 Trial

Apremilast, an oral phosphodiesterase 4 inhibitor, inpatients with nail, scalp, and palmoplantar psoriasis:52-week ESTEEM 2 study results

Assessing skin diseases in patients with pigmented skin(a grey area)

Assessment of attitudes towards sun-protectivebehaviour in Australia: a cross-sectional studyA. Lee

Assessment of delays to diagnosis of nodularmelanoma compared to superficial spreadingmelanoma

Assessment of pharmacists’ knowledge about use oftopical corticosteroids in atopic dermatitis: pre- andpost-continuing professional development education